Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonia Reimer

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Pediatric Dermatology|January 11, 2024
Osteoporosis and bone health in pediatric patients with epidermolysis bullosa: A scoping reviewAndie Kwon, Austin Hwang, Corinne H Miller, et al.
Orphanet Journal of Rare Diseases|May 20, 2024
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 casesAustin Hwang, Andie Kwon, Corinne H Miller, et al.
Acta Dermato-Venereologica|December 16, 2017
The Position of Targeted Next-generation Sequencing in Epidermolysis Bullosa DiagnosisCristina Has, Julia Küsel, Antonia Reimer, et al.
Acta Dermato-Venereologica|July 3, 2018
Successful Multidisciplinary Treatment of Chronic Facial Wounds in Junctional Epidermolysis BullosaAntonia Reimer, Roland Laszig, Jens Pfeiffer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2025
Pathophysiological insights into the successful treatment of EBV-positive hydroa vacciniforme lymphoproliferative disorder with hydroxychloroquineChristina Bürgler, Lukas Meyer-Landolt, Stefanie Häfliger, et al.
The Journal of Investigative Dermatology|February 12, 2022
Predominance of Staphylococcus Correlates with Wound Burden and Disease Activity in Dystrophic Epidermolysis Bullosa: A Prospective Case-Control StudyAntonia Reimer-Taschenbrecker, Axel Künstner, Misa Hirose, et al.
Pediatric Dermatology|December 3, 2022
Gastrostomy tube feeding in epidermolysis bullosa: A multi-center assessment of caregiver satisfactionElana P Kleinman, Antonia Reimer-Taschenbrecker, Courtney N Haller, et al.
Clinical Immunology (Orlando, Fla.)|June 14, 2019
Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutationsMaria E Maccari, Carsten Speckmann, Maximilian Heeg, et al.
The British Journal of Dermatology|February 10, 2023
A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblingsMingfeng Li, Kenneth Lay, Andreas Zimmer, et al.
Eclinicalmedicine|November 14, 2024
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trialDimitra Kiritsi, Franziska Schauer, Stella Gewert, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pediatric Dermatology|January 11, 2024
Osteoporosis and bone health in pediatric patients with epidermolysis bullosa: A scoping reviewAndie Kwon, Austin Hwang, Corinne H Miller, et al.
Orphanet Journal of Rare Diseases|May 20, 2024
Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 casesAustin Hwang, Andie Kwon, Corinne H Miller, et al.
Acta Dermato-Venereologica|December 16, 2017
The Position of Targeted Next-generation Sequencing in Epidermolysis Bullosa DiagnosisCristina Has, Julia Küsel, Antonia Reimer, et al.
Acta Dermato-Venereologica|July 3, 2018
Successful Multidisciplinary Treatment of Chronic Facial Wounds in Junctional Epidermolysis BullosaAntonia Reimer, Roland Laszig, Jens Pfeiffer, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2025
Pathophysiological insights into the successful treatment of EBV-positive hydroa vacciniforme lymphoproliferative disorder with hydroxychloroquineChristina Bürgler, Lukas Meyer-Landolt, Stefanie Häfliger, et al.
The Journal of Investigative Dermatology|February 12, 2022
Predominance of Staphylococcus Correlates with Wound Burden and Disease Activity in Dystrophic Epidermolysis Bullosa: A Prospective Case-Control StudyAntonia Reimer-Taschenbrecker, Axel Künstner, Misa Hirose, et al.
Pediatric Dermatology|December 3, 2022
Gastrostomy tube feeding in epidermolysis bullosa: A multi-center assessment of caregiver satisfactionElana P Kleinman, Antonia Reimer-Taschenbrecker, Courtney N Haller, et al.
Clinical Immunology (Orlando, Fla.)|June 14, 2019
Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutationsMaria E Maccari, Carsten Speckmann, Maximilian Heeg, et al.
The British Journal of Dermatology|February 10, 2023
A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblingsMingfeng Li, Kenneth Lay, Andreas Zimmer, et al.
Eclinicalmedicine|November 14, 2024
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trialDimitra Kiritsi, Franziska Schauer, Stella Gewert, et al.
Pageof 3